Compare Enveric Biosciences Inc (ENVB) vs Southern Copper Corp (SCCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Southern Copper Corp — how do they compare? Enveric Biosciences Inc trades at $1.38 (market cap $5.32M), while Southern Copper Corp trades at $175.08 (market cap $151.46B). The key difference: Southern Copper Corp is far larger — about 28469.9× Enveric Biosciences Inc's market cap, and Southern Copper Corp pays a 2.2% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | SCCO | |
|---|---|---|
Market Cap | $5.32M | $151.46B |
Sector | Health | Basic Materials |
52-Week High | $17.40 | $218.85 |
52-Week Low | $1.28 | $90.54 |
Enterprise Value | $408.82K | $153.52B |
Dividend Yield | — | 2.2% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.38, up 4.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported a net loss of $8.77M for 2025, though it beat EPS estimates in all four quarters. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003, including IND-enabling studies and positive preclinical results.
Outlook hinges on clinical progress, with 75% analyst buy ratings supporting potential upside, but high financial losses and negative ROE/ROA pose significant risks. Investors face volatility from regulatory developments and funding needs, making it speculative despite positive sentiment from recent operational updates.
SCCO trades at $175.9, down 3.55% today, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.90 exceeding the $1.82 estimate. Revenue grew to $13.42 billion in 2025, and net income margin expanded to 34.13%. A $1.00 dividend was declared for H1 2026, payable on May 29, 2026.
Outlook remains positive due to robust profitability and growth, but high valuation ratios (P/E 30.73, P/S 10.51) and mixed analyst sentiment pose risks. Copper demand from AI and electrification trends supports long-term prospects, yet price volatility and economic cycles are key concerns for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Southern Copper Corp
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →
